Phase II/III proof-of-concept trial investigating the effectiveness and safety of eprodisate to treat certain medical manifestations of sarcoidosis
Phase of Trial: Phase II/III
Latest Information Update: 12 Nov 2015
Price : $35 *
At a glance
- Drugs Eprodisate (Primary)
- Indications Pulmonary sarcoidosis; Sarcoidosis
- Focus Proof of concept; Therapeutic Use
- 12 Nov 2015 According to BELLUS Health media release, an investigational new drug application (IND) is expected to be filled with the U.S. FDA in the first half of 2016.
- 25 Feb 2015 According to a Bellus Health media release, this trial is expected to begin in mid-2015.
- 25 Feb 2015 Planned initiation date changed from 1 Dec 2014 to 1 Jul 2015 according to a Bellus Health media release.